story of the week
Influence of Personalized Extended-Interval Dosing on the Natalizumab Wearing-Off Effect
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the Neurological Sciences
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
J. Neurol. Sci. 2024 Jun 22;462(xx)123102, AA Toorop, MHJ Wessels, LMY Gelissen, E Hoitsma, EMPE Zeinstra, LC van Rooij, CEP van Munster, A Vennegoor, JP Mostert, BHA Wokke, NF Kalkers, ELJ Hoogervorst, JJJ van Eijk, CM Roosendaal, JJ Kragt, M Eurelings, J van Genugten, J Nielsen, LGF Sinnige, ME Kloosterziel, EPJ Arnoldus, GW van Dijk, WH Bouvy, EMM Strijbis, BW van Oosten, BA de Jong, BI Lissenberg-Witte, T Rispens, BMJ Uitdehaag, J Killestein, ZLE van KempenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.